SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)
Taiwan · Delayed Price · Currency is TWD 72.50
+0.30 (0.42%)
At close: Mar 3, 2026
SYN-TECH Chem. & Pharm. Revenue
In the year 2025, SYN-TECH Chem. & Pharm. had annual revenue of 1.30B TWD with 3.39% growth. SYN-TECH Chem. & Pharm. had revenue of 322.95M in the quarter ending December 31, 2025, with 2.76% growth.
Revenue
1.30B
Revenue Growth
+3.39%
P/S Ratio
2.49
Revenue / Employee
5.73M
Employees
227
Market Cap
3.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.30B | 42.58M | 3.39% |
| Dec 31, 2024 | 1.26B | 142.98M | 12.83% |
| Dec 31, 2023 | 1.11B | 128.39M | 13.02% |
| Dec 31, 2022 | 986.30M | 93.07M | 10.42% |
| Dec 31, 2021 | 893.23M | -90.56M | -9.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.14B |
| Apex Biotechnology | 1.96B |
| Genovate Biotechnology | 492.41M |
| Sagittarius Life Science | 424.44M |
| 3D Global Biotech | 324.87M |
| Intech Biopharm | 113.85M |
| GlycoNex Incorporation | 36.63M |
| ACRO Biomedical | 36.50M |